PWRD [Perfect World] 6-K: Perfect World Co., Ltd. Kelvin Wing Kee Lau
[Perfect World Co., Ltd. Kelvin Wing Kee Lau Chief Financial Officer 2 Page]
TPI [TIANYIN PHARMACEUTICAL] 10-Q/A: FORM 10-Q/A (Amendment No. 1) (Mark One) For
[FORM 10-Q/A (Amendment No. 1) (Mark One) For the quarterly period ended March 31, 2011 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer,]
UTSI [UTSTARCOMSRP.] 6-K: UTStarcom Announcesmpany Stock Repurchase Program of Up to
[UTStarcom Announcesmpany Stock Repurchase Program of Up to $20 Million and Management Stock Repurchase Program of Up to $0.5 Million BEIJING, CHINA August15, 2011 UTStarcomsrp. (UTStarcom or thempany) (Nasdaq: UTSI) a leading provider of interactive,IP-based network solutions in iDTV,IPTV,Internet TV and Broadband forble and telecom operators today announced that its board of directors has approved]
GSH [GUANGSHEN RAILWAY CO] 6-K: (Original Filing)
[Guangshen Railway Announces 2011 Interim Results Net Profit Rises 47.20% to RMB915 million HONG KONG, Aug. 18, 2011 /PRNewswire-Asia/ -- Operating revenues amounted to RMB6,934 million, representing a year-on-year increase of 9.90%. Revenues from passenger transportation rose 10.88% year-on-year to RMB3,908 million. Revenues from freight transportation rose 4.58% year-on-year to RMB643 million. Consolidated profit attributable to] [2 Chapter 1 Important Notice 5 Chapter 2 Basic Information on the Company 7 Chapter 3 Change in Share Capital and Shareholding of Major Shareholders 11 Chapter 4 Directors, Supervisors and Senior Management 12 Chapter 5 21 Chapter 6 Matters of Importance 27] [Number Description of Document 99.1 Press release dated August 18, 2011 99.2 Interim Report 2011 2]
TPI [TIANYIN PHARMACEUTICAL] 10-Q/A: (Original Filing)
[FORM 10-Q/A (Amendment No. 1) (Mark One) For the quarterly period ended December 31, 2010 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer, Director]
DSWL [DESWELL INDUSTRIES] 6-K: (Original Filing)
[17B, Edificiomercial Rodrigues 599 Avenida Praia Grande STYLE="font-family:Times New Roman" SIZE="2">Macao,R, To the shareholders of Deswell Industries,: The annual meeting of the shareholders of Deswell Industries, (Deswell or thempany) will be held at the Sutton Room of the Four Seasons Hotel, 57 East 57th Street, New York City, New York, USA on September22, 2011 at]
GSH [GUANGSHEN RAILWAY CO] 6-K: Guangshen Railway Announces 2011 Interim Results Net Profit
[Guangshen Railway Announces 2011 Interim Results Net Profit Rises 47.20% to RMB915 million HONG KONG, Aug. 18, 2011 /PRNewswire-Asia/ -- Operating revenues amounted to RMB6,934 million, representing a year-on-year increase of 9.90%. Revenues from passenger transportation rose 10.88% year-on-year to RMB3,908 million. Revenues from freight transportation rose 4.58% year-on-year to RMB643 million. Consolidated profit attributable to] [2 Chapter 1 Important Notice 5 Chapter 2 Basic Information on the Company 7 Chapter 3 Change in Share Capital and Shareholding of Major Shareholders 11 Chapter 4 Directors, Supervisors and Senior Management 12 Chapter 5 21 Chapter 6 Matters of Importance 27] [Number Description of Document 99.1 Press release dated August 18, 2011 99.2 Interim Report 2011 2]
TPI [TIANYIN PHARMACEUTICAL] 10-Q/A: (Original Filing)
[FORM 10-Q/A (Amendment No.1) (Mark One) For the quarterly period ended September 30, 2010 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer, Director]
DSWL [DESWELL INDUSTRIES] 6-K: 17B, Edificiomercial Rodrigues 599 Avenida Praia Grande STYLE=”font-family:Times
[17B, Edificiomercial Rodrigues 599 Avenida Praia Grande STYLE="font-family:Times New Roman" SIZE="2">Macao,R, To the shareholders of Deswell Industries,: The annual meeting of the shareholders of Deswell Industries, (Deswell or thempany) will be held at the Sutton Room of the Four Seasons Hotel, 57 East 57th Street, New York City, New York, USA on September22, 2011 at]
